Quality problems for China's electromagnetic devices:
This article was originally published in Clinica
Nearly 40% of electromagnetic medical devices manufactured in China do not conform to quality standards, a recent State Pharmaceutical Administration of China survey found. The SPAC inspected 42 devices manufactured by enterprises in Beijing, Shanghai, Tianjin, Liaoning, Hebei, Jiangsu, Sichuan and Guangdong and found 16 failed to comply with the relevant standard.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.